Trial updateRetina
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Active, not recruiting. Phase 3. Registered enrolment: 313. Stealth BioTherapeutics Inc.
Why it matters
Track this study through NCT06373731. No results are posted in this registry record.
The study at a glance
- Registry status
- Active, not recruiting
- Phase
- Phase 3
- Registered enrolment
- 313
- Results posted
- No
- Sponsor
- Stealth BioTherapeutics Inc.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.
References (1)
Source date: 17 Sept 2026 · United States · Czechia · Germany · Hungary · Italy · New Zealand · Spain · United Kingdom